![Karen Wagner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Wagner
Directeur/Membre du Conseil chez
Vivet Therapeutics SAS
Profil
Karen Wagner is currently a Director at Aelix, Inc., Galecto Biotech ApS, Minoryx Therapeutics SL, Aelix Therapeutics SL, SparingVision SAS, and Vivet Therapeutics SAS. She is also a Board Member at CytoKi Pharma ApS.
Previously, she worked as a Director-Global Alliance at F.
Hoffmann-La Roche Ltd. from 2005 to 2014.
She was also a Director at KALA BIO, Inc., Ingenium Pharmaceuticals GmbH, RSPR Pharma AB, Xeltis AG, Galecto, Inc., and Roche Glycart AG.
Before that, she was a Consultant & Member-Global Healthcare Practice at McKinsey & Co., Inc. (Switzerland).
Dr. Wagner holds a graduate and doctorate degree from Universität Konstanz.
Postes actifs de Karen Wagner
| Sociétés | Poste | Début |
|---|---|---|
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements. | Private Equity Investor | 01/08/2007 |
Vivet Therapeutics SAS
 Vivet Therapeutics SAS BiotechnologyHealth Technology Operates as a clinical-stage emerging biotechnology company that develops novel gene therapy treatments for rare and inherited metabolic diseases | Directeur/Membre du Conseil | - |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Develops pharmaceutical products | Directeur/Membre du Conseil | - |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Directeur/Membre du Conseil | 26/10/2018 |
Aelix, Inc.
 Aelix, Inc. Internet Software/ServicesTechnology Services Provides intelligent communications solutions to enterprises, notably in the travel and hospitality financial services and electronic commerce sectors | Directeur/Membre du Conseil | - |
SparingVision SAS
 SparingVision SAS BiotechnologyHealth Technology Develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa | Directeur/Membre du Conseil | - |
Aelix Therapeutics SL
 Aelix Therapeutics SL BiotechnologyHealth Technology Develops novel vaccines to cure HIV infection | Directeur/Membre du Conseil | - |
CytoKi Pharma ApS
 CytoKi Pharma ApS Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Directeur/Membre du Conseil | - |
Anciens postes connus de Karen Wagner
| Sociétés | Poste | Fin |
|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/12/2014 |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Karen Wagner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
49
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kala Bio, Inc.
 Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Ingenium Pharmaceuticals GmbH
 Ingenium Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapeutic drugs | Commercial Services |
Aelix, Inc.
Aelix, Inc. Internet Software/ServicesTechnology Services Provides intelligent communications solutions to enterprises, notably in the travel and hospitality financial services and electronic commerce sectors | Technology Services |
Roche Glycart AG
 Roche Glycart AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that engages in research, development and commercialization of antibody-based products | Health Technology |
Universität Konstanz
 Universität Konstanz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements. | Finance |
RSPR Pharma AB
 RSPR Pharma AB Pharmaceuticals: MajorHealth Technology Develops therapeutics for inflammatory vascular diseases | Health Technology |
Mckinsey & Co., Inc. (Switzerland) | |
Xeltis AG
 Xeltis AG Medical SpecialtiesHealth Technology Develops medical devices for heart valve replacement and vascular surgery | Health Technology |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Health Technology |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
Aelix Therapeutics SL
Aelix Therapeutics SL BiotechnologyHealth Technology Develops novel vaccines to cure HIV infection | Health Technology |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology Develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa | Health Technology |
Vivet Therapeutics SAS
Vivet Therapeutics SAS BiotechnologyHealth Technology Operates as a clinical-stage emerging biotechnology company that develops novel gene therapy treatments for rare and inherited metabolic diseases | Health Technology |
CytoKi Pharma ApS
CytoKi Pharma ApS Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Commercial Services |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
